List of Histogen, Inc. patents

List of Histogen, Inc. patents

List of WAKAMOTO PHARMACEUTICAL CO., LTD. patents

List of HELIX BIOMEDIX patents

List of Marvell Semiconductor patents

List of SBIR/STTR awards granted to Reveal Pharmaceuticals

List of funding rounds for Letstransport.In

Patents where

Current Assignee

Name

is

Histogen, Inc.

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 11274276 Conditioned medium and extracellular matrix compositions from cells cultured under hypoxic conditions	Patent 11274276 was granted and assigned to Histogen, Inc. on March, 2022 by the United States Patent and Trademark Office.	Histogen, Inc.	Histogen, Inc.		United States Patent and Trademark Office	11274276	March 15, 2022
	‌ US Patent 9034312 Extracellular matrix compositions for the treatment of cancer	Patent 9034312 was granted and assigned to Histogen, Inc. on May, 2015 by the United States Patent and Trademark Office.		Histogen, Inc.		United States Patent and Trademark Office	9034312	May 19, 2015
	‌ US Patent 11447497 (S)-3-(2-(4-(benzyl)-3-oxopiperazin-1-yl)acetamido)-4-oxo-5-(2,3,5,6-tetrafluorophenoxy)pentanoic acid derivatives and related compounds as caspase inhibitors for treating cardiovascular diseases	Patent 11447497 was granted and assigned to Histogen, Inc. on September, 2022 by the United States Patent and Trademark Office.	Histogen, Inc.	Histogen, Inc.		United States Patent and Trademark Office	11447497	September 20, 2022
	‌ US Patent 11597703 Caspase inhibitors and methods of use thereof		Histogen, Inc.	Histogen, Inc.		United States Patent and Trademark Office	11597703	March 7, 2023
	‌ US Patent 9506038 Extracellular matrix compositions for the treatment of cancer	Patent 9506038 was granted and assigned to Histogen, Inc. on November, 2016 by the United States Patent and Trademark Office.	Histogen, Inc.	Histogen, Inc.		United States Patent and Trademark Office	9506038	November 29, 2016
	‌ US Patent 10538736 Conditioned medium and extracellular matrix compositions from cells cultured under hypoxic conditions	Patent 10538736 was granted and assigned to Histogen, Inc. on January, 2020 by the United States Patent and Trademark Office.	Histogen, Inc.	Histogen, Inc.		United States Patent and Trademark Office	10538736	January 21, 2020
	‌ US Patent 9512403 Conditioned medium and extracellular matrix compositions from cells cultured under hypoxic conditions for methods of treating tissue injury	Patent 9512403 was granted and assigned to Histogen, Inc. on December, 2016 by the United States Patent and Trademark Office.	Histogen, Inc.	Histogen, Inc.		United States Patent and Trademark Office	9512403	December 6, 2016
	‌ US Patent 8852637 Extracellular matrix compositions for the treatment of cancer	Patent 8852637 was granted and assigned to Histogen, Inc. on October, 2014 by the United States Patent and Trademark Office.		Histogen, Inc.		United States Patent and Trademark Office	8852637	October 7, 2014
	‌ US Patent 8530415 Repair and/or regeneration of cells with a composition produced by culturing fibroblast cells under hypoxic conditions	Patent 8530415 was granted and assigned to Histogen, Inc. on September, 2013 by the United States Patent and Trademark Office.		Histogen, Inc.		United States Patent and Trademark Office	8530415	September 10, 2013
	‌ US Patent 10143708 Extracellular matrix compositions for the treatment of cancer	Patent 10143708 was granted and assigned to Histogen, Inc. on December, 2018 by the United States Patent and Trademark Office.	Histogen, Inc.	Histogen, Inc.		United States Patent and Trademark Office	10143708	December 4, 2018
	‌ US Patent 8524494 Low oxygen tension and BFGF generates a multipotent stem cell from a fibroblast in vitro	Patent 8524494 was granted and assigned to Histogen, Inc. on September, 2013 by the United States Patent and Trademark Office.		Histogen, Inc.		United States Patent and Trademark Office	8524494	September 3, 2013
	‌ US Patent 8535913 Soluble composition for promoting hair growth produced by hypoxic culture of fibroblasts cells			Histogen, Inc.		United States Patent and Trademark Office	8535913	September 17, 2013

12 results

0 selected

12 results

0 selected